PULMATRIX, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
PULMATRIX, INC. (PULM) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period of 724.17 thousand shares for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-26.
Discontinued › Notes › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod · last filed 2020-03-26
- PULMATRIX, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2019-12-31 was 188.67K shares, a 292.58% increase year-over-year.
- PULMATRIX, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2019-09-30 was 338.37K shares, a 1999.98% increase year-over-year.
- PULMATRIX, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2019-06-30 was 51.54K shares, a 998.76% increase year-over-year.
- PULMATRIX, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2019-03-31 was 145.58K shares, a 6268.37% increase year-over-year.
- PULMATRIX, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2019 was 724.17K shares, a 917.80% increase from fiscal 2018.
- PULMATRIX, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2018 was 71.15K shares, a 21.47% decline from fiscal 2017.
- PULMATRIX, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2017 was 90.60K shares, a 64.03% decline from fiscal 2016.
- PULMATRIX, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2016 was 251.84K shares, a 12379.73% increase from fiscal 2015.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month |
|---|---|---|---|---|
| 2019-12-31 | 188.67K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | 527.04K shares derived: sum of 2 quarters · filed 2020-03-26 | 578.59K shares derived: sum of 3 quarters · filed 2020-03-26 | 724.17K shares 10-K · filed 2020-03-26 |
| 2019-09-30 | 338.37K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-01 | 389.91K shares derived: sum of 2 quarters · filed 2019-11-01 | 535.49K shares 10-Q · filed 2019-11-01 | 583.55K shares derived: sum of 4 quarters · filed 2019-11-01 |
| 2019-06-30 | 51.54K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | 197.12K shares 10-Q · filed 2019-08-05 | 245.18K shares derived: sum of 3 quarters · filed 2019-08-05 | 261.30K shares derived: sum of 4 quarters · filed 2019-08-05 |
| 2019-03-31 | 145.58K shares 10-Q · filed 2019-05-15 | 193.64K shares derived: sum of 2 quarters · filed 2019-05-15 | 209.75K shares derived: sum of 3 quarters · filed 2019-05-15 | 214.44K shares derived: sum of 4 quarters · filed 2019-05-15 |
| 2018-12-31 | 48.06K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | 64.17K shares derived: sum of 2 quarters · filed 2019-02-19 | 68.86K shares derived: sum of 3 quarters · filed 2019-02-19 | 71.15K shares 10-K · filed 2019-02-19 |
| 2018-09-30 | 16.11K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | 20.80K shares derived: sum of 2 quarters · filed 2018-11-14 | 23.09K shares 10-Q · filed 2018-11-14 | 27.82K shares derived: sum of 4 quarters · filed 2018-11-14 |
| 2018-06-30 | 4.69K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | 6.98K shares 10-Q · filed 2018-08-03 | 11.71K shares derived: sum of 3 quarters · filed 2018-08-03 | 16.15K shares derived: sum of 4 quarters · filed 2018-08-03 |
| 2018-03-31 | 2.29K shares 10-Q · filed 2018-05-11 | 7.02K shares derived: sum of 2 quarters · filed 2018-05-11 | 11.46K shares derived: sum of 3 quarters · filed 2018-05-11 | 38.06K shares derived: sum of 4 quarters · filed 2018-05-11 |
| 2017-12-31 | 4.73K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | 9.17K shares derived: sum of 2 quarters · filed 2018-03-13 | 35.77K shares derived: sum of 3 quarters · filed 2018-03-13 | 90.60K shares 10-K · filed 2018-03-13 |
| 2017-09-30 | 4.44K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | 31.04K shares derived: sum of 2 quarters · filed 2017-11-09 | 85.86K shares 10-Q · filed 2017-11-09 | 274.04K shares derived: sum of 4 quarters · filed 2017-11-09 |
| 2017-06-30 | 26.60K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | 81.42K shares 10-Q · filed 2017-08-04 | 269.60K shares derived: sum of 3 quarters · filed 2017-08-04 | 286.97K shares derived: sum of 4 quarters · filed 2017-08-04 |
| 2017-03-31 | 54.82K shares 10-Q · filed 2017-05-05 | 243.00K shares derived: sum of 2 quarters · filed 2017-05-05 | 260.36K shares derived: sum of 3 quarters · filed 2017-05-05 | 306.66K shares derived: sum of 4 quarters · filed 2017-05-05 |
| 2016-12-31 | 188.18K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | 205.54K shares derived: sum of 2 quarters · filed 2017-03-10 | 251.84K shares derived: sum of 3 quarters · filed 2017-03-10 | 251.84K shares 10-K · filed 2017-03-10 |
| 2016-09-30 | 17.36K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | 63.66K shares derived: sum of 2 quarters · filed 2016-11-04 | 63.66K shares 10-Q · filed 2016-11-04 | 63.66K shares derived: sum of 4 quarters · filed 2016-11-04 |
| 2016-06-30 | 46.30K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | 46.30K shares 10-Q · filed 2016-08-04 | 46.30K shares derived: sum of 3 quarters · filed 2016-08-04 | 46.30K shares derived: sum of 4 quarters · filed 2016-08-04 |
| 2016-03-31 | 0.00 shares 10-Q · filed 2016-05-05 | 0.00 shares derived: sum of 2 quarters · filed 2016-05-05 | 2.00 shares derived: sum of 3 quarters · filed 2016-05-05 | |
| 2015-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | 2.00 shares derived: sum of 2 quarters · filed 2016-03-10 | 2.02K shares 10-K · filed 2016-03-10 | |
| 2015-09-30 | 2.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | 2.02K shares 10-Q · filed 2015-11-12 | ||
| 2015-06-30 | 2.02K shares 10-Q · filed 2015-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |